Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Lifecare AS ( (DE:LFC0) ) has issued an announcement.
Lifecare ASA announced the commencement of the exercise period for 4,193,806 warrants related to its rights issue of new shares. The exercise of these warrants allows holders to subscribe for new shares, with unexercised warrants lapsing without compensation. Hannibal Invest AS, associated with a board member, has exercised 1,335 warrants. The new shares are expected to be registered and listed on Euronext Oslo Børs by late June 2025, impacting the company’s share capital and potentially diluting existing shareholders’ stakes.
More about Lifecare AS
Lifecare ASA is a medical sensor company focused on developing technology for sensing and monitoring various body analytes, with a particular emphasis on advancing Continuous Glucose Monitoring (CGM) systems. The company’s sensor technology is designed to identify and monitor a wide range of analytes and molecules in both humans and pets.
Average Trading Volume: 40,922
Current Market Cap: NOK106.5M
Find detailed analytics on LFC0 stock on TipRanks’ Stock Analysis page.